Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole

Objective: The purpose of this study was to assess change in body mass index (BMI) and age- and gender-adjusted BMI Z-score in subjects ages 2–20 years with autism spectrum disorders (ASD), who were treated longitudinally with risperidone or aripiprazole at a tertiary care ASD clinic. Method: As par...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Child Adolesc Psychopharmacol
Main Authors: Wink, Logan K., Early, Maureen, Schaefer, Tori, Pottenger, Amy, Horn, Paul, McDougle, Christopher J., Erickson, Craig A.
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248544/
https://ncbi.nlm.nih.gov/pubmed/24564519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2013.0099
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados